Three clean lanes exist: hang manufacturer-sealed bags exactly as labeled (that's administration — no hood, no compounding rules at all); buy premixed cocktails from a licensed compounding pharmacy (your staff stays on the administration side); or mix on-site under USP 797's "immediate-use" provision, which permits hood-free preparation within strict, checkable conditions.
Settled: mixing additives into a bag is sterile compounding under USP 797; spiking a sealed manufactured bag is not. USP itself enforces nothing — your state board does.
Contested: whether the immediate-use lane is open to retail and mobile IV businesses at all. Some boards say no, one state is proposing yes, and in a few states the deciding question is who may mix rather than where. Both readings are below.
What's settled
Mixing into the bag is compounding. Spiking the bag is not.
Everything hangs on this line, and USP draws it clearly. Sterile compounding is combining, admixing, diluting, pooling, reconstituting, or otherwise altering a drug to create a sterile preparation — and, as the American Association of Nurse Anesthesiology's summary of the revised chapter puts it, spiking a conventionally manufactured bag without further manipulation is administration, which sits entirely outside USP 797's scope.
So: hang a sealed bag of lactated Ringer's as labeled — administration. Push B12, magnesium, and vitamin C into that same bag — you've created a compounded sterile preparation. That definition isn't disputed anywhere, and it's not a gotcha: it's the sorting fact that tells you which lane you're in.
Combining products changes what's in the bag: compatibility (some additives precipitate together), stability (some degrade once diluted), and osmolarity — the particle concentration of the final solution. Blood runs ~285–295 mOsm/L; every additive raises the number, and the Infusion Nurses Society's standards put the commonly cited peripheral-vein ceiling near 900 mOsm/L. A stacked cocktail is a new preparation with its own chemistry — which is why the rules attach to the act of mixing, not to the business doing it.
The three clean lanes
- Administration only. Your menu uses manufacturer-sealed products hung exactly per labeling. No compounding occurs, no hood enters the conversation, and USP 797 doesn't apply to the visit. Simple, fully compliant, and more of the market runs this way than you'd guess.
- Premixed from a licensed compounder. A 503A compounding pharmacy prepares patient-specific cocktails from prescriptions, or an FDA-registered 503B outsourcing facility produces batches under full manufacturing controls. Your staff receives sealed, labeled bags and stays on the administration side of the line — which works in every state, including the strictest. Trade-offs to price out: higher per-bag cost, a fixed menu, real inventory discipline (premixed bags carry their own beyond-use dates), and a patient-specific order is still required. Verify the pharmacy is licensed in your state.
- Immediate-use mixing on-site. USP 797's immediate-use provision permits limited compounding without a hood when every condition is met. The conditions are hard-edged and checkable — which is good news, because it means you can audit your own menu against them today. They're next.
Immediate-use: the exact conditions
Per USP's own materials on the 2023 revision, immediate-use preparation qualifies when all of the following hold: not more than 3 different sterile products; administration begins within 4 hours of the start of preparation, or the bag is discarded; aseptic technique with documented training and written SOPs; preparation follows evidence-based compatibility information; and single-dose containers serve one patient only.
The one to check first is the product count, because it surprises people: saline is one sterile product, so a bag plus two additives fits — but a bag plus B-complex, B12, vitamin C, magnesium, and zinc may be six. Some of the industry's best-selling cocktails don't fit the immediate-use lane as-built. That's not a death sentence; it's a menu-design fact. Operators handle it by reformulating flagship drips to fit, moving the heavy cocktails to premixed (lane 2), or stepping up to a hood — and the 2023 revision genuinely widened this lane: the old 1-hour window stretched to 4 hours, and the old emergency-only framing was dropped.
Where a hood fits, if you need one
A "hood" — formally a primary engineering control — is an ISO Class 5 workbench bathing the work surface in HEPA-filtered air. It protects the preparation, not the operator. In USP's structure it's the next rung up from immediate-use: Category 1 compounding happens in a hood inside a segregated compounding area (a defined, low-traffic space) and earns a 12-hour beyond-use date; Category 2 and 3 are full cleanroom suites — pharmacy territory. So a hood isn't a general requirement for IV businesses; it's the specific equipment for one specific lane, and it lives in a proper space, not a storage closet. A fixed med spa or lounge location can build that space if the menu justifies it; a vehicle can't, which is one honest reason mobile operators lean on lanes 1 and 2.
USP enforces nothing. Your state board decides.
The revised Chapter 797 became official November 1, 2023, and compliance is enforced by your state — in practice the board of pharmacy, sometimes jointly with the medical and nursing boards. States adopt 797 wholesale, adapt it, or layer their own statutes on top, which is why the same bag mixed the same way can be routine in one state and a violation in the next. One useful honesty note: no public, authoritative state-by-state chart of these requirements exists. The Alliance for Pharmacy Compounding maintains a state-adoption tracker as a members-only resource, and beyond that, your state board's own guidance is the source of record — which is exactly why the question list at the end of this guide exists.
What's contested: is the immediate-use lane open to this business model?
Here's where qualified authorities genuinely part ways, and you deserve the honest version rather than a confident-sounding one.
The reading that says no
Wisconsin's Interdisciplinary Advisory Committee — its medical, pharmacy, nursing, PA, cosmetology, and controlled-substances boards together — issued joint guidance in October 2025 stating that adding medications, vitamins, minerals, or amino acids to IV bags is compounding, that only licensed pharmacists or physicians may compound, and that the immediate-use provision does not change that. Kansas followed in February 2026: its Board of Healing Arts and Board of Pharmacy jointly stated that IV therapy is a medical practice requiring licensed professionals. Maryland's Board of Pharmacy said at its July 2023 meeting that introducing vitamins into a sterile IV bag constitutes compounding, to be performed under a hood. California's Board of Pharmacy holds in a formal policy statement that creating menu-style mixtures is sterile compounding. Wisconsin built its guidance after reviewing seven other states, drawing on an Arizona Board of Nursing advisory opinion and a South Carolina joint board advisory — this conversation is spreading board to board.
The reading that says yes — sometimes
USP's own 2023 text deliberately removed the emergency-only framing: immediate-use now applies to "direct and immediate administration" wherever its conditions are met, with the situation left to facility SOPs. On this reading, a single-patient bag, three or fewer sterile products, competent technique, and a running 4-hour clock is exactly what the provision describes — in a hospital, a lounge, or a living room. And Mississippi has proposed rules expressly permitting IV hydration solutions to be compounded outside a pharmacy by nurses and nurse practitioners in a clinic — a direct regulatory embrace of the model other boards are cautioning against.
Both readings can be right at once, because they answer different questions. USP's text describes conditions; the restrictive boards are ruling on who may perform the act under state law. A preparation can satisfy every immediate-use condition and still sit outside what a state's pharmacy act permits your staff to do. The hood question and the authority question look identical from the outside — and they are not.
We're not going to pretend this is resolved. The same USP sentence is being read in opposite directions by state boards in the same year. If a guide answers this flatly, it's more certain than the regulators are. What you can do is know which reading your state has taken — or that it hasn't taken one yet — and build accordingly.
The question a hood can't answer
In Wisconsin's guidance and Kansas's statement, only pharmacists and physicians may compound — nurses under direct physician supervision, pharmacy technicians only inside a licensed pharmacy. Ohio's joint regulatory statement builds a similar structure, and adds — as several states now have — that blanket standing orders are not valid prescriptions, because a real patient-provider relationship has to sit behind each order. (That's the compounding-side twin of the Good Faith Exam: someone with prescriptive authority decides, for this patient, what goes in this bag. Our Good Faith Exam guide covers that half.)
The practical takeaway isn't alarming — it's clarifying: in a who-may-compound state, the equipment question is moot, and the workable structures are known. Pharmacist involvement, genuinely structured physician supervision, or lane 2's premixed bags all satisfy it. What doesn't work is buying a hood and assuming the rest follows.
Picking your lane
Walk this with counsel and your board's actual guidance, not any article:
- Sealed bags only? You're in lane 1 — administering, not compounding. Done.
- Menu too rich for three products, or you're in a state that's spoken? Price out lane 2. Premixed from a licensed 503A/503B works everywhere, and for many operators the margin math is better than the buildout math.
- Mixing on-site in a state that's silent? You're in lane 3 — audit your footing: count the sterile products in your best-seller, run the 4-hour clock against your real workflow (for mobile, the clock starts at preparation, so mix at the point of care rather than at base), and put aseptic training and SOPs in writing. Documentation is what turns "we're careful" into something you can show.
- Menu needs more than immediate-use allows and you want to mix in-house? That's the hood conversation — a Category 1 setup in a proper segregated space, realistic for a fixed location with the volume to justify it.
If you're launching now, you get to pick your lane before you have habits, inventory, or a menu to unwind — an advantage every established operator wishes they had. Design the menu to fit the lane (or the lane to fit the menu), write the SOPs on day one, and the compounding question becomes a line item in your launch plan instead of a retrofit. The operators getting caught out are overwhelmingly the ones who never chose.
What to ask a health care attorney (and your board of pharmacy)
Most of what's unsettled here turns on your state and your specific menu — which is exactly what one focused hour with counsel can resolve. Bring this list:
- Has my state's board — or a joint board committee — issued IV hydration guidance, and what does it say about immediate-use?
- Under my state's pharmacy act, who may compound: pharmacists and physicians only, or nurses under supervision — and what does "direct supervision" mean here?
- Do my best-selling formulas exceed three sterile products — and if so, which path fits: reformulation, premixed bags, or a Category 1 setup?
- Do my orders come from a real patient-specific encounter, or a standing-order list my state may not honor?
- If I run mobile: where does preparation legally happen, and when does the 4-hour clock start against my actual dispatch-to-door timeline?
- Does the 3-product limit apply per preparation or per patient encounter — and would splitting one therapy across sequential bags be viewed as circumvention?
Infuse Pro won't make your mixing compliant with USP 797 — no software can. What it does is keep the record straight around the bag: the patient-specific provider evaluation before treatment, the order attached to the chart, the visit documented at the point of care with timestamps that show your sequence held. Whichever lane you pick, the visit you ran is the visit you can show you ran.
The quick version
- Three clean lanes: sealed bags as labeled (administration), premixed from a licensed 503A/503B compounder, or on-site immediate-use mixing within its conditions
- Settled: mixing additives into a bag is sterile compounding; spiking an unmodified manufactured bag is not — and USP enforces nothing, your state board does
- Settled: immediate-use is hood-free but hard-edged — ≤3 sterile products, 4-hour clock, documented aseptic competency, single patient; audit your menu against the product count
- Contested: whether the immediate-use lane is open to retail and mobile IV businesses — Wisconsin, Kansas, Maryland, and California read it restrictively; Mississippi is proposing the opposite
- Contested: who may compound at all — in several states only pharmacists and physicians, which equipment can't change and premixed bags sidestep
- No public state-by-state chart exists — your board's guidance is the source of record; the attorney list above is built for that conversation
Run an IV operation you can stand behind
Booking, the provider evaluation workflow, HIPAA charting at the point of care, and payment — connected in one platform, so the visit you run is the visit you can document.
See how it works →